Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H8WZ
|
||||
Former ID |
DIB004173
|
||||
Drug Name |
SR-43845
|
||||
Synonyms |
N-[3-(3-Pyridyl)propionyl]-L-phenylalanyl-L-histidyl-cyclostatinyl-L-isoleucyl-1,1-di(hydroxymethyl)ethylamide; N-[3-(3-Pyridyl)propionyl]-L-phenylalanyl-L-histidyl-(3S,4S)-4-amino-3-hydroxy-5-cyclohexylpentanoyl-L-isoleucyl-1,1-di(hydroxymethyl)ethylamide; [S-(R*,R*)]-5-Cyclohexyl-2,4,5-trideoxy-N-[1-[[[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]amino]carbonyl]-2-methylbutyl]-4-[[N-[N-[1-oxo-3-(3-pyridinyl)propyl]-L-phenylalanyl]-L-histidyl]amino-L-threo
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Glaucoma [ICD9: 365; ICD10:H40-H42] | Phase 2 | [544840] | ||
Structure |
Download2D MOL |
||||
Formula |
C44H64N8O8
|
||||
Canonical SMILES |
CCC(C)C(C(=O)NC(C)(CO)CO)NC(=O)CC(C(CC1CCCCC1)NC(=O)C(C<br />C2=CN=CN2)NC(=O)C(CC3=CC=CC=C3)NC(=O)CCC4=CN=CC=C4)O
|
||||
InChI |
1S/C44H64N8O8/c1-4-29(2)40(43(60)52-44(3,26-53)27-54)51-39(57)23-37(55)34(20-30-12-7-5-8-13-30)49-42(59)36(22-33-25-46-28-47-33)50-41(58)35(21-31-14-9-6-10-15-31)48-38(56)18-17-32-16-11-19-45-24-32/h6,9-11,14-16,19,24-25,28-30,34-37,40,53-55H,4-5,7-8,12-13,17-18,20-23,26-27H2,1-3H3,(H,46,47)(H,48,56)(H,49,59)(H,50,58)(H,51,57)(H,52,60)
|
||||
InChIKey |
NZGWKVVFXREROW-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 114037-60-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Renin, renal | Target Info | Inhibitor | [533331], [551871] | |
KEGG Pathway | Renin-angiotensin system | ||||
PathWhiz Pathway | Angiotensin Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.